Related Experiment Video
Updated: Jun 6, 2025

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
DJ-1-mediated repression of the RNA-binding protein FMRP is predicted to impact known Alzheimer's disease-related
Ayse Uneri1, Colin J McArdle1, Zhiyong Deng1
1Department of Translational Neuroscience, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA.
Background:
RNA-binding proteins (RBPs) modulate the synaptic proteome and are instrumental in maintaining synaptic homeostasis. Moreover, aberrant expression of an RBP in a disease state would have deleterious downstream effects on synaptic function. While many underlying mechanisms of synaptic dysfunction in Alzheimer's disease (AD) have been proposed, the contribution of RBPs has been relatively unexplored.
Objective:
To investigate alterations in RBP-messenger RNA (mRNA) interactions in AD, and its overall impact on the disease-related proteome.
Methods:
We first utilized RNA-immunoprecipitation to investigate interactions between RBP, DJ-1 (Parkinson's Disease protein 7) and target mRNAs in controls and AD. Surface Sensing of Translation - Proximity Ligation Assay (SUnSET-PLA) and western blotting additionally quantified alterations in mRNA translation and protein expression of DJ-1 targets. Finally, we utilized an unbiased bioinformatic approach that connects AD-related pathways to two RBPs, DJ-1 and FMRP (Fragile X messenger ribonucleoprotein 1).
Results:
We find that oligomeric DJ-1 in AD donor synapses were less dynamic in their ability to bind and unbind mRNA compared to synapses from cognitively unimpaired, neuropathologically-verified controls. Furthermore, we find that DJ-1 associates with the mRNA coding for FMRP, Fmr1, leading to its reduced synaptic expression in AD. Through the construction of protein-protein interaction networks, aberrant expression of DJ-1 and FMRP are predicted to lead to the upregulation of key AD-related pathways, such as thyroid hormone stimulating pathway, autophagy, and ubiquitin mediated proteolysis.
Conclusions:
DJ-1 and FMRP are novel targets that may restore established neurobiological mechanisms underlying AD.
Insights
RNA-binding proteins DJ-1 and FMRP are implicated in Alzheimer's disease (AD) synaptic dysfunction. Their altered interactions impact mRNA translation and protein expression, potentially driving AD-related pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- RNA-binding proteins (RBPs) regulate synaptic function and homeostasis.
- Dysfunctional RBPs contribute to neurological disorders like Alzheimer's disease (AD).
- The role of RBPs in AD pathogenesis remains largely unexplored.
Purpose of the Study:
- To investigate alterations in RBP-mRNA interactions in AD.
- To determine the impact of these changes on the AD-related proteome.
- To identify novel therapeutic targets for AD.
Main Methods:
- RNA-immunoprecipitation to study RBP-mRNA interactions.
- Surface Sensing of Translation - Proximity Ligation Assay (SUnSET-PLA) and western blotting to quantify translation and protein expression.
- Bioinformatic analysis to link AD pathways to RBPs DJ-1 and FMRP (Fragile X messenger ribonucleoprotein 1).
Main Results:
- Oligomeric DJ-1 exhibits reduced mRNA binding dynamics in AD synapses.
- DJ-1 associates with FMRP mRNA (Fmr1), decreasing synaptic FMRP expression in AD.
- Aberrant DJ-1 and FMRP expression are predicted to upregulate AD-related pathways (thyroid hormone, autophagy, ubiquitin-mediated proteolysis).
Conclusions:
- DJ-1 and FMRP are novel therapeutic targets for AD.
- Modulating DJ-1 and FMRP may restore neurobiological mechanisms in AD.
- This study highlights the critical role of RBPs in AD synaptic dysfunction.
More Related Videos
Related Concept Videos
Experimental RNAi
MicroRNAs
RNA Editing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Stability
Types of RNA
RNA Performs Diverse...

